OriGene Technologies Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:OriGene Technologies Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10873
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and markets genome research and diagnostic products. OriGene provides products such as qPCR reagents, transfection reagent, precisionshuttling kits, cDNA clones, HuSH shRNA, plasmid purification, siRNA, miRNA, proteins antibodies, IHC products, assays and human tissues, among others. The company provides services such asd gene synthesis, custom shRNA, custom cloning, custom protein service, antibody service, assay development and stable cell line development. It offers research in the areas of cancer biomarker research, pathology IHC, stem cell research, ion channels, protein kinase, and others. The company provides products and services to pharmaceutical and biotechnology companies and academic research institutes. OriGene is headquartered in Rockville, Maryland, the US.

OriGene Technologies Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OriGene Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OriGene Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 10
Venture Financing 12
OriGene Technologies Raises USD6.4 Million in Venture Financing 12
OriGene Technologies Raises Funds in Financing Round 13
OriGene Technologies Raises USD17 Million in Venture Financing 14
OriGene Technologies Raises USD0.2 Million in Venture Financing 15
OriGene Technologies Raises US$21 Million In Series C Financing 16
Origene Technologies Raises US$15 Million In Venture Financing 17
Partnerships 18
OriGene Technologies Enters into Contract with National Cancer Institute 18
Entia Biosciences Enters Into Co-Development Agreement With Biocheck 19
Licensing Agreements 20
Dako Enters into Licensing Agreement with OriGene Technologies 20
Asset Transactions 21
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 21
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 23
Acquisition 24
OriGene Technologies Acquires Acris Antibodies 24
OriGene Technologies Inc – Key Competitors 25
OriGene Technologies Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Key Facts 2
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OriGene Technologies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OriGene Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 10
OriGene Technologies Raises USD6.4 Million in Venture Financing 12
OriGene Technologies Raises Funds in Financing Round 13
OriGene Technologies Raises USD17 Million in Venture Financing 14
OriGene Technologies Raises USD0.2 Million in Venture Financing 15
OriGene Technologies Raises US$21 Million In Series C Financing 16
Origene Technologies Raises US$15 Million In Venture Financing 17
OriGene Technologies Enters into Contract with National Cancer Institute 18
Entia Biosciences Enters Into Co-Development Agreement With Biocheck 19
Dako Enters into Licensing Agreement with OriGene Technologies 20
Strategic Diagnostics Completes Sale Of Life Science Business Assets To OriGene For US$16 Million 21
Romer Labs Completes Acquisition Of Food Safety And GMO Business Of Strategic Diagnostics For US$13.5 Million 23
OriGene Technologies Acquires Acris Antibodies 24
OriGene Technologies Inc, Key Competitors 25
OriGene Technologies Inc, Subsidiaries 26

List of Figures
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
OriGene Technologies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
OriGene Technologies Inc, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[OriGene Technologies Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tose Co., Ltd. (4728):企業財務及び戦略的SWOT分析
    Summary TOSE CO., LTD. (TOSE) is a technology company that offers software solutions. The company plans, develops and operates entertainment software and mobile internet software. It operates through its business segments such as game software development and mobile development. TOSE’s game software …
  • Evgen Pharma Plc (EVG):企業財務及び戦略的SWOT分析
    Summary Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Limited is a drug discovery company that develops medicines with concentration on cancer and neurological diseases. The company carries out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. It uses su …
  • Energiekontor AG (EKT):企業の財務及び戦略的SWOT分析
    Summary Energiekontor AG (Energiekontor) is an alternative energy company which develops and operates wind energy products. The company’s core business extends from planning and construction to operation management of wind farms in Germany and abroad. It operates through its subsidiaries in the UK a …
  • Viridian Energy Supply Ltd.(エネルギー分野):企業M&A動向
    Summary Viridian Energy Supply Ltd, doing business as Energia, is an Ireland-based vertically integrated energy company. The company is a subsidiary of Viridian Group Limited. The company procures, transmits, distributes and supplies power. Energia also supplies gas to a large number of industrial a …
  • Alliance Data Systems Corporation:企業のM&A・提携・投資分析
    Alliance Data Systems Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Alliance Data Systems Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Kiadis Pharma NV (KDS):製薬・医療:M&Aディール及び事業提携情報
    Summary Kiadis Pharma NV (Kiadis) is a biopharmaceutical company that develops and markets cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company offers cellular products including ATIR101 and ATIR201 for infusion. Its ATIR101 lowers the risks …
  • James Fisher and Sons plc (FSJ):企業財務及び戦略的SWOT分析
    Summary James Fisher and Sons plc (James Fisher) is a service provider that focuses on global marine industry and a specialist supplier of engineering services to the energy industry. The company provides comprehensive services such as exploration, production, decommissioning, diving and ROV, inspec …
  • Hill and Smith Holdings PLC:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hill and Smith Holdings PLC Mer …
  • Dedeman Hotels and Resorts International:企業概要及びSWOT分析
    Summary Canadean's "Dedeman Hotels and Resorts International: Travel and Tourism - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business …
  • HalcyGen Pharmaceuticals Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' HalcyGen Pharmaceuticals Limite …
  • Paddy Power plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Paddy Power plc Mergers and Acq …
  • IXICO Plc (IXI):企業の財務・戦略的SWOT分析
    Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints and assessing the safety and efficacy of drugs. The company offers products such as Assessa and trial tracker. Assessa provides web-based platform to tra …
  • Tohoku Electric Power Co., Inc. (9506):企業のM&A・提携動向(エネルギー分野)
    Summary Tohoku Electric Power Co., Inc. (Tohoku EPCO) is an electric utility company that generates, transmits and distributes electricity in Japan. It generates electricity through various sources such as thermal, geothermal, wind, solar, biomass and nuclear. Tohoku EPCO also undertakes constructio …
  • Peak Oil & Gas Limited (PKO):企業概要、財務及び戦略的SWOT分析
    Summary Peak Oil & Gas Limited (Peak Oil) is an energy company. The company explores and develops crude oil, natural gas and uranium assets. Its projects include SC6C Cadlao, South Block A and Sunday Creek. Peak Oil’s SC6C Cadlao project is located in the Palawan Basin; South Block A project is situ …
  • Aldi Einkauf GmbH & Co oHG:戦略・SWOT・企業財務分析
    Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report Summary Aldi Einkauf GmbH & Co oHG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Rock-Tenn Company:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Rock-Tenn Company Mergers and A …
  • Misonix Inc (MSON)-医療機器分野:企業M&A・提携分析
    Summary Misonix Inc (Misonix) is a medical technology company that provides ultrasonic surgical devices for neurosurgical, spinal, advanced wound care and general surgery procedures. The company’s major products include BoneScalpel cutting system; SonaStar surgical aspirator; SonicOne wound cleansin …
  • CoreLogic, Inc. (CLGX):企業財務及び戦略的SWOT分析
    Summary CoreLogic, Inc. (CoreLogic) is a financial service provider company that provides information, analytics and services. The company offers solutions such as licensing, direct marketing, flood services, consumer finance, credit union, advisory services, automotive credit reporting, data and an …
  • Enable Injections, LLC:企業のM&A・提携動向(医療機器分野)
    Summary Enable Injections, LLC (Enable Injections) is a medical device company that develops and manufactures disposable body-worn bolus injector that allows patient self-administration of viscosity drugs. The company develops different injector systems including syringe transfer system, vial transf …
  • Samsung Electronics Co., Ltd. (005930)(エネルギー分野):企業M&A動向
    Summary Samsung Electronics Co., Ltd. (Samsung) is one of the leading manufacturers of semiconductors, information technology products, digital media, and telecommunication infrastructure systems. Samsung also produces components such as semiconductors, LCD panels, compressors, and storage and fiber …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆